Over the next few years, the market for general surgical devices in the United Arab Emirates is expected to grow at a CAGR of 6.2%.
The COVID-19 pandemic impacted the market significantly. The market was adversely impacted during the initial phase of the pandemic due to the lockdowns and shutdowns. However, the United Arab Emirates government continued normal operations in the healthcare system following proper regulations and restrictions. This created opportunities for various surgical procedures. Additionally, due to the increasing number of hospital admissions and increasing cases of obesity in the country, bariatric surgeries were allowed in the United Arab Emirates. For instance, according to a study published in June 2022 in Bariatric Surgical Practice and Patient Care, it has been observed that bariatric procedures in the country continued even during the peak phase of the pandemic, and some of the healthcare facilities were approved as COVID-19-free facilities by the United Arab Emirates government regulations to perform such surgeries. Thus, the ongoing surgical procedures during the pandemic have created a demand for surgical devices, which has impacted the market's growth. Moreover, the growing number of surgeries performed in the country after the COVID-19 pandemic as well as the device launches have increased the demand for technologically advanced surgical devices, and the studied market is expected to regain its full potential after the pandemic in the next two to three years.
The general surgical devices market is growing because of things like more people wanting minimally invasive surgeries, more injuries and accidents, and more money being spent on health care in the country.
The rising number of road traffic accidents and injuries among the target population is expected to increase the demand for surgical procedures, which in turn is anticipated to fuel market growth over the forecast period. For instance, as per an article published by NCBI in December 2021, it has been observed that the number of traffic fatalities has increased by 20% in the United Arab Emirates in 2021 as compared to the previous year. Also, as per the data published by the United Arab Emirates Road Safety in June 2022, it has been observed that 3,488 crashes were recorded in the United Arab Emirates in 2021, as compared to 2,931 in 2020, including 1,031 collisions and 548 accidents, as compared to 816 collisions and 492 accidents in 2020. Thus, the increasing number of road accidents and road injury cases raises the demand for emergency surgical procedures, which is expected to increase the demand for efficient surgical devices. This is anticipated to fuel market growth.
The country is improving its surgical facilities by building new, state-of-the-art surgical centers that concentrate on using cutting-edge surgical and medical technology for patient care. For instance, in August 2022, Dubai Hospital opened a new outpatient building with 128 specialized clinics equipped with the latest technology, with an investment of USD 48 million. Also, in May 2022, Aster Hospitals United Arab Emirates opened its first full-fledged oncology section at its branch in Al Qusais, Dubai, in response to a significant increase in demand for cancer screenings and treatment. The new facility initially focuses on surgical and medical oncology and offers expert cancer care with an emphasis on integrative treatment. So, these changes and improvements in hospitals lead to a high demand for surgical tools in the country, which helps the market grow.
Furthermore, the growing acceptance of minimally invasive, robotic, and computer-assisted surgery is likely to drive market growth over the forecast period. For instance, in May 2022, Dubai Hospital launched the Da Vinci Xi Surgical Robot for performing robotic-assisted minimally invasive surgeries. The robot has advanced laparoscopic surgical technologies that help improve services in the United Arab Emirates for both general surgery and laparoscopic surgery.
Moreover, the increasing demand for minimally invasive surgeries and the emerging technological advancements in surgical products and their growing adoption are also contributing to the market's growth. For instance, in June 2022, the Advanced Microfluidics and Microdevices Laboratory (AMMLab) at NYU Abu Dhabi (NYUAD) developed a simple but efficient method for on-demand tactile sensing in minimally invasive surgery. The new tool is a laparoscopic grasper with an off-the-shelf sensor built in. This sensor helps sense tissues during an operation.
Therefore, owing to the abovementioned factors, the market under study is expected to witness growth. But strict government rules and bad ways of paying for surgical devices are likely to slow the growth of the market for general surgical devices over the next few years.
In addition, the presence of well-established healthcare infrastructure in the country also increases the demand for advanced surgical devices, thereby propelling segment growth. For instance, as per the data published by the ITA in July 2022, the United Arab Emirates is one of the most economically developed and diversified markets with a strong healthcare infrastructure. In addition, as per the same source, the government approved a federal budget of USD 15.8 billion (AED 58.931 billion) for public spending, of which 8.4% is dedicated to healthcare.
Cardiovascular disease (CVD) is the major cause of mortality in the country. For instance, as per an article published in the American Journal of Preventive Cardiology in December 2021, it has been observed that the United Arab Emirates has the second-highest cardiovascular mortality rate after Saudi Arabia and is higher than the average for Gulf Cooperation Council (GCC) nations. This is anticipated to increase the demand for cardiovascular surgeries, thereby boosting the growth of cardiology devices over the forecast period.
Additionally, according to the 2022 statistics published by the IDF, about 0.99 million people were living with diabetes in 2021 in the United Arab Emirates, and this number is projected to double by 2050. Thus, the expected increase in the diabetic population in the country may lead to a rise in cardiovascular complications, which is anticipated to boost the demand for surgeries, hence propelling the market's growth.
Similarly, as per a meta-analysis study published in December 2021, it has been observed that the combined prevalence of hypertension ranges between 20 and 35% in the country. In addition, as per the same source, the prevalence of hypertension was higher in Dubai than in the Abu Dhabi region. Thus, the elevated blood pressure in the population causes the left ventricle to thicken, which increases the risk of heart attack and cardiac failure. This is expected to augment segment growth over the forecast period.
Furthermore, the rising company activities and increasing focus on the adoption of various business strategies such as collaboration, partnerships, and others to develop advanced handheld devices for managing cardiovascular conditions This is also expected to drive segment growth over the forecast period. For instance, in March 2022, BioIntellisense, Inc. entered into a strategic collaboration with Mubadala Health to develop remote care technologies to drive clinical workflow efficiencies, unlock data-driven clinical insights, and deliver a personalized care experience. This collaboration with Mubadala Health offers a tremendous opportunity to apply the BioSticker and BioButton wearable medical devices in a variety of healthcare settings, simplify early detection, and provide care teams with individualized clinical intelligence that enables proactive, well-informed interventions.
So, the studied segment is likely to grow over the next few years due to the factors mentioned above, such as the growing number of cardiovascular diseases and the factors that go with them, as well as the growth of company activities.
The rising burden of cancer, liver diseases, obesity, and others is the key factor driving the need for surgeries, hence propelling the demand for laparoscopic devices. For instance, according to the GLOBOCAN report, the estimated number of new breast cancer cases in the United Arab Emirates (UAE) is projected to reach 2,306 by 2040. As per the same source, about 2,306 new breast cancer cases are expected to be diagnosed in the United Arab Emirates by 2040.
Additionally, according to an article published in July 2021, about 372,000 people are projected to develop non-alcoholic fatty liver disease (NAFLD) in the United Arab Emirates by 2030. In addition, as per the same source, the prevalence of NAFLD was expected to rise by 87% by 2030 in the UAE. Thus, the expected increase in the population suffering from NAFLD is expected to increase the demand for laparoscopic surgeries, which in turn is anticipated to propel the demand for laparoscopic devices and laparoscopes, hence boosting segment growth.
The growing demand for minimally invasive surgeries (MIS) also increased market growth, as they cause less post-operative pain and patients receive smaller dosages of painkillers. As only minimal cuts or stitches are involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. Also, the advantages of MIS over traditional open surgeries include producing a better and magnified image of the organs or body parts being operated on and higher precision due to video-assisted equipment.
Furthermore, the rising technological advancements and emerging trends of robotic surgery by surgeons during complex surgeries are expected to increase the market's growth over the forecast period. For instance, in October 2022, Sheikh Shakhbout Medical City (SSMC) performed its first robot-assisted gynecological surgery to treat abdominal pain in a patient due to a large pelvic mass on the left ovary. Also, in June 2022, Muna Kishwai performed robotic surgery to perform total and supra-cervical hysterectomies, cure uterine prolapse, and remove fibroids at a government-run hospital in the UAE.
Therefore, owing to factors such as the rising burden of chronic diseases, the increasing advantages of minimally invasive surgeries, and the increasing adoption of robotic and computerized surgeries in the country, the studied segment is expected to grow over the forecast period.
This product will be delivered within 2 business days.
The COVID-19 pandemic impacted the market significantly. The market was adversely impacted during the initial phase of the pandemic due to the lockdowns and shutdowns. However, the United Arab Emirates government continued normal operations in the healthcare system following proper regulations and restrictions. This created opportunities for various surgical procedures. Additionally, due to the increasing number of hospital admissions and increasing cases of obesity in the country, bariatric surgeries were allowed in the United Arab Emirates. For instance, according to a study published in June 2022 in Bariatric Surgical Practice and Patient Care, it has been observed that bariatric procedures in the country continued even during the peak phase of the pandemic, and some of the healthcare facilities were approved as COVID-19-free facilities by the United Arab Emirates government regulations to perform such surgeries. Thus, the ongoing surgical procedures during the pandemic have created a demand for surgical devices, which has impacted the market's growth. Moreover, the growing number of surgeries performed in the country after the COVID-19 pandemic as well as the device launches have increased the demand for technologically advanced surgical devices, and the studied market is expected to regain its full potential after the pandemic in the next two to three years.
The general surgical devices market is growing because of things like more people wanting minimally invasive surgeries, more injuries and accidents, and more money being spent on health care in the country.
The rising number of road traffic accidents and injuries among the target population is expected to increase the demand for surgical procedures, which in turn is anticipated to fuel market growth over the forecast period. For instance, as per an article published by NCBI in December 2021, it has been observed that the number of traffic fatalities has increased by 20% in the United Arab Emirates in 2021 as compared to the previous year. Also, as per the data published by the United Arab Emirates Road Safety in June 2022, it has been observed that 3,488 crashes were recorded in the United Arab Emirates in 2021, as compared to 2,931 in 2020, including 1,031 collisions and 548 accidents, as compared to 816 collisions and 492 accidents in 2020. Thus, the increasing number of road accidents and road injury cases raises the demand for emergency surgical procedures, which is expected to increase the demand for efficient surgical devices. This is anticipated to fuel market growth.
The country is improving its surgical facilities by building new, state-of-the-art surgical centers that concentrate on using cutting-edge surgical and medical technology for patient care. For instance, in August 2022, Dubai Hospital opened a new outpatient building with 128 specialized clinics equipped with the latest technology, with an investment of USD 48 million. Also, in May 2022, Aster Hospitals United Arab Emirates opened its first full-fledged oncology section at its branch in Al Qusais, Dubai, in response to a significant increase in demand for cancer screenings and treatment. The new facility initially focuses on surgical and medical oncology and offers expert cancer care with an emphasis on integrative treatment. So, these changes and improvements in hospitals lead to a high demand for surgical tools in the country, which helps the market grow.
Furthermore, the growing acceptance of minimally invasive, robotic, and computer-assisted surgery is likely to drive market growth over the forecast period. For instance, in May 2022, Dubai Hospital launched the Da Vinci Xi Surgical Robot for performing robotic-assisted minimally invasive surgeries. The robot has advanced laparoscopic surgical technologies that help improve services in the United Arab Emirates for both general surgery and laparoscopic surgery.
Moreover, the increasing demand for minimally invasive surgeries and the emerging technological advancements in surgical products and their growing adoption are also contributing to the market's growth. For instance, in June 2022, the Advanced Microfluidics and Microdevices Laboratory (AMMLab) at NYU Abu Dhabi (NYUAD) developed a simple but efficient method for on-demand tactile sensing in minimally invasive surgery. The new tool is a laparoscopic grasper with an off-the-shelf sensor built in. This sensor helps sense tissues during an operation.
Therefore, owing to the abovementioned factors, the market under study is expected to witness growth. But strict government rules and bad ways of paying for surgical devices are likely to slow the growth of the market for general surgical devices over the next few years.
UAE General Surgical Devices Market Trends
Cardiology Segment is Anticipated to Witness Growth Over the Forecast Period
The cardiology segment is expected to witness significant growth in the general surgical devices market in the United Arab Emirates over the forecast period owing to factors such as the rising prevalence of cardiovascular diseases such as stroke, hypertension, and heart attack and their associated risk factors.In addition, the presence of well-established healthcare infrastructure in the country also increases the demand for advanced surgical devices, thereby propelling segment growth. For instance, as per the data published by the ITA in July 2022, the United Arab Emirates is one of the most economically developed and diversified markets with a strong healthcare infrastructure. In addition, as per the same source, the government approved a federal budget of USD 15.8 billion (AED 58.931 billion) for public spending, of which 8.4% is dedicated to healthcare.
Cardiovascular disease (CVD) is the major cause of mortality in the country. For instance, as per an article published in the American Journal of Preventive Cardiology in December 2021, it has been observed that the United Arab Emirates has the second-highest cardiovascular mortality rate after Saudi Arabia and is higher than the average for Gulf Cooperation Council (GCC) nations. This is anticipated to increase the demand for cardiovascular surgeries, thereby boosting the growth of cardiology devices over the forecast period.
Additionally, according to the 2022 statistics published by the IDF, about 0.99 million people were living with diabetes in 2021 in the United Arab Emirates, and this number is projected to double by 2050. Thus, the expected increase in the diabetic population in the country may lead to a rise in cardiovascular complications, which is anticipated to boost the demand for surgeries, hence propelling the market's growth.
Similarly, as per a meta-analysis study published in December 2021, it has been observed that the combined prevalence of hypertension ranges between 20 and 35% in the country. In addition, as per the same source, the prevalence of hypertension was higher in Dubai than in the Abu Dhabi region. Thus, the elevated blood pressure in the population causes the left ventricle to thicken, which increases the risk of heart attack and cardiac failure. This is expected to augment segment growth over the forecast period.
Furthermore, the rising company activities and increasing focus on the adoption of various business strategies such as collaboration, partnerships, and others to develop advanced handheld devices for managing cardiovascular conditions This is also expected to drive segment growth over the forecast period. For instance, in March 2022, BioIntellisense, Inc. entered into a strategic collaboration with Mubadala Health to develop remote care technologies to drive clinical workflow efficiencies, unlock data-driven clinical insights, and deliver a personalized care experience. This collaboration with Mubadala Health offers a tremendous opportunity to apply the BioSticker and BioButton wearable medical devices in a variety of healthcare settings, simplify early detection, and provide care teams with individualized clinical intelligence that enables proactive, well-informed interventions.
So, the studied segment is likely to grow over the next few years due to the factors mentioned above, such as the growing number of cardiovascular diseases and the factors that go with them, as well as the growth of company activities.
Laparoscopic Devices Segment is Expected to Have the Significant Market Share Over the Forecast Period
The laparoscopic devices segment is expected to witness healthy growth in the general surgical device market over the forecast period owing to factors such as the rising prevalence of chronic diseases, increasing technological advancements, and rising demand for minimally invasive surgical procedures.The rising burden of cancer, liver diseases, obesity, and others is the key factor driving the need for surgeries, hence propelling the demand for laparoscopic devices. For instance, according to the GLOBOCAN report, the estimated number of new breast cancer cases in the United Arab Emirates (UAE) is projected to reach 2,306 by 2040. As per the same source, about 2,306 new breast cancer cases are expected to be diagnosed in the United Arab Emirates by 2040.
Additionally, according to an article published in July 2021, about 372,000 people are projected to develop non-alcoholic fatty liver disease (NAFLD) in the United Arab Emirates by 2030. In addition, as per the same source, the prevalence of NAFLD was expected to rise by 87% by 2030 in the UAE. Thus, the expected increase in the population suffering from NAFLD is expected to increase the demand for laparoscopic surgeries, which in turn is anticipated to propel the demand for laparoscopic devices and laparoscopes, hence boosting segment growth.
The growing demand for minimally invasive surgeries (MIS) also increased market growth, as they cause less post-operative pain and patients receive smaller dosages of painkillers. As only minimal cuts or stitches are involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. Also, the advantages of MIS over traditional open surgeries include producing a better and magnified image of the organs or body parts being operated on and higher precision due to video-assisted equipment.
Furthermore, the rising technological advancements and emerging trends of robotic surgery by surgeons during complex surgeries are expected to increase the market's growth over the forecast period. For instance, in October 2022, Sheikh Shakhbout Medical City (SSMC) performed its first robot-assisted gynecological surgery to treat abdominal pain in a patient due to a large pelvic mass on the left ovary. Also, in June 2022, Muna Kishwai performed robotic surgery to perform total and supra-cervical hysterectomies, cure uterine prolapse, and remove fibroids at a government-run hospital in the UAE.
Therefore, owing to factors such as the rising burden of chronic diseases, the increasing advantages of minimally invasive surgeries, and the increasing adoption of robotic and computerized surgeries in the country, the studied segment is expected to grow over the forecast period.
UAE General Surgical Devices Market Competitor Analysis
The general surgical devices market in the United Arab Emirates is competitive and consists of several market players. These players are focusing on research and development to create stable and safe devices for surgical procedures. The market has been noticing technological developments on a large scale for the past decade. Medtronic PLC, Stryker Corporation, B. Braun SE, Smith & Nephew, Olympus Corporations, and 3M are among the market participants.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun SE
- Johnson & Johnson
- Stryker Corporation
- Boston Scientific Corporation
- Olympus Corporation
- Medtronic PLC
- Getinge AB
- Smith + Nephew
- 3M
Methodology
LOADING...
